(MedPage Today) — CHICAGO — Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in the near future, with results after 1 year reported here from one of its key phase III trials.
Further…
Webinar on allied health and nursing to be held on May 11
With the growing demand for quality healthcare services, allied health and nursing professionals are playing an increasingly significant role in...






